missing translation for 'onlineSavingsMsg'
Learn More
Learn More
BD Biosciences™ IMK-Lymphocyte (CE/IVD)
Description
- Two-color direct immunofluorescence reagent kit for enumerating percentages of the following mature human leuKocyte subsets in erythrocyte-lysed whole blood (LWB): T (CD3+) lymphocytes, B (CD19+) lymphocytes, helper/inducer T (CD3+CD4+) lymphocytes, suppressor/cytotoxic T (CD3+CD8+) lymphocytes, and natural killer (NK) (CD3–CD16+and/or CD56+) lymphocytes.
- The helper/suppressor T-lymphocyte ratio (CD3+CD4+/CD3+CD8+) can also be determined.
Specifications
Specifications
| Applications | Flow Cytometry |
| Formulation | Leucogate (CD45/CD14), Control Reagent (ITC-labeled IgG1, clone X40, and PE-labeled IgG2a, clone X39), CD3/CD19, CD3/CD4, CD3/CD8, CD3/CD16+CD5, FACS Lysing Solution |
| Quantity | 1 Kit |
| Regulatory Status | CE, IVD |
| Target Species | Human |
| Content And Storage | When stored at 2°C to 8°C, antibody reagents are stable until the expiration date shown on the label. Do not use after the expiration date. Antibody reagensst should not be frozen or exposed to direct light during storage or during incubation with cells. Keep the reagent vial dry. Incubation or centrifugation times or temperatures other than those specified can be a source of error. For optimal results, stain blood samples within 6 hours of venipuncture. Alteration in the appearance of any of the reagents, such as precipitation or discoloration, indicates instability or deterioration. In such cases, the reagent should not be used. The antibody reagents contain sodium azide as a preservative; however, care should be taken to avoid microbial contamination, which can cause erroneous results. |
| Product Type | Immunofluorescence and flow cytometry test |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?